---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-284002"
form_type: "8-K"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2026-06-26T12:30:06+00:00"
generated_at: "2026-06-26T12:35:24.580599+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Wave Life Sciences shareholders approve redomiciliation; 155M shares voted in favor

## Summary
- Scheme Shareholders voted 155,190,836 for (99.9%) and 78,429 against; all 87 shareholders voted in favor.
- Redomiciliation expected to take effect in mid-2026, subject to Singapore High Court approval.
- Scheme of Arrangement approved under Singapore law; company to seek court confirmation.

## SEC filing metadata
- accession: 0001193125-26-284002
- form_type: 8-K
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2026-06-26T12:30:06+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312526284002/0001193125-26-284002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312526284002/d70732d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-284002
- JSON: https://secwatch.observer/filing/0001193125-26-284002.json
- Plain text: https://secwatch.observer/filing/0001193125-26-284002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.